Cargando…

The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma

The Hippo-TAZ signaling has emerged as a fundamental regulator underlying cancer stem cells (CSCs) stemness which intricately associates with local recurrence and metastatic spreading in head neck squamous cell carcinoma (HNSCC). However, the precise downstream targets of TAZ responsible for HNSCC C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jin, Li, Zhongwu, Wu, Yaping, Wang, Yanling, Wang, Dongmiao, Zhang, Wei, Yuan, Hua, Ye, Jinhai, Song, Xiaomeng, Yang, Jianrong, Jiang, Hongbing, Cheng, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689034/ https://www.ncbi.nlm.nih.gov/pubmed/31399556 http://dx.doi.org/10.1038/s41419-019-1838-0

Ejemplares similares

Therapeutic Targeting of BRD4 in Head Neck Squamous Cell Carcinoma
por: Wu, Yaping, et al.
Publicado: (2019)

Pharmacological activation of TAZ enhances osteogenic differentiation and bone formation of adipose-derived stem cells
por: Zhu, Yumin, et al.
Publicado: (2018)

SUZ12 is a novel putative oncogene promoting tumorigenesis in head and neck squamous cell carcinoma
por: Wu, Yaping, et al.
Publicado: (2018)

The effector of Hippo signaling, Taz, is required for formation of the micropyle and fertilization in zebrafish
por: Yi, Xiaogui, et al.
Publicado: (2019)

TEAD4 overexpression promotes epithelial-mesenchymal transition and associates with aggressiveness and adverse prognosis in head neck squamous cell carcinoma
por: Zhang, Wei, et al.
Publicado: (2018)

Restoration of TET2 deficiency inhibits tumor growth in head neck squamous cell carcinoma
por: Huang, Rong, et al.
Publicado: (2020)

Pro-Invasive Activity of the Hippo Pathway Effectors YAP and TAZ in Cutaneous Melanoma
por: Nallet-Staub, Flore, et al.
Publicado: (2014)

Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis
por: Wang, Haichuan, et al.
Publicado: (2020)

The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma
por: Mohamed, Abdalla, et al.
Publicado: (2016)

Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone
por: Isfort, Ilka, et al.
Publicado: (2019)

Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomas
por: Escoll, Maribel, et al.
Publicado: (2020)

Therapeutically targeting head and neck squamous cell carcinoma through synergistic inhibition of LSD1 and JMJD3 by TCP and GSK-J1
por: Zhang, Wei, et al.
Publicado: (2019)

Overexpression of ZEB2‐AS1 promotes epithelial‐to‐mesenchymal transition and metastasis by stabilizing ZEB2 mRNA in head neck squamous cell carcinoma
por: Diao, Pengfei, et al.
Publicado: (2019)

The pluripotency factor LIN28B is involved in oral carcinogenesis and associates with tumor aggressiveness and unfavorable prognosis
por: Wang, Dongmiao, et al.
Publicado: (2015)

Genomic Hippo Pathway Alterations and Persistent YAP/TAZ Activation: New Hallmarks in Head and Neck Cancer
por: Faraji, Farhoud, et al.
Publicado: (2022)

The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
por: Cigliano, Antonio, et al.
Publicado: (2022)

Expression Pattern of the Hippo Pathway Effector TAZ in Cellular and Fibrotic Nonspecific Interstitial Pneumonia
por: Yeo, Min-Kyung, et al.
Publicado: (2018)

Identification of a Transcriptional Prognostic Signature From Five Metabolic Pathways in Oral Squamous Cell Carcinoma
por: Wu, Xiang, et al.
Publicado: (2020)

Pharmacological inhibition of Bmi1 by PTC-209 impaired tumor growth in head neck squamous cell carcinoma
por: Wang, Qiong, et al.
Publicado: (2017)

The Hippo Pathway Effectors YAP/TAZ Are Essential for Mineralized Tissue Homeostasis in the Alveolar Bone/Periodontal Complex
por: Pandya, Mirali, et al.
Publicado: (2022)

Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018)

Common and Distinctive Functions of the Hippo Effectors Taz and Yap in Skeletal Muscle Stem Cell Function
por: Sun, Congshan, et al.
Publicado: (2017)

Modeling the Control of TGF-β/Smad Nuclear Accumulation by the Hippo Pathway Effectors, Taz/Yap
por: Labibi, Bita, et al.
Publicado: (2020)

Dedifferentiation by adenovirus E1A due to inactivation of Hippo pathway effectors YAP and TAZ
por: Zemke, Nathan R., et al.
Publicado: (2019)

The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment
por: Mokhtari, Reza Bayat, et al.
Publicado: (2023)

Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms
por: Dobrokhotov, Oleg, et al.
Publicado: (2018)

CDK7 regulates organ size and tumor growth by safeguarding the Hippo pathway effector Yki/Yap/Taz in the nucleus
por: Cho, Yong Suk, et al.
Publicado: (2020)

HOXB7 acts as an oncogenic biomarker in head and neck squamous cell carcinoma
por: Wu, Xiang, et al.
Publicado: (2021)

Overexpression of suppressor of zest 12 is associated with cervical node metastasis and unfavorable prognosis in tongue squamous cell carcinoma
por: Hu, Huijun, et al.
Publicado: (2017)

Hippo-Yap/Taz signalling in zebrafish regeneration
por: Riley, Susanna E., et al.
Publicado: (2022)

Hippo Pathway and YAP Signaling Alterations in Squamous Cancer of the Head and Neck
por: Santos-de-Frutos, Karla, et al.
Publicado: (2019)

The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer
por: Li, Zhongwu, et al.
Publicado: (2013)

Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
por: Chan, Siew Wee, et al.
Publicado: (2011)

Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
por: Boopathy, Gandhi T. K., et al.
Publicado: (2019)

Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway
por: Vanyai, Hannah K., et al.
Publicado: (2020)

Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinib
por: Xu, Wei, et al.
Publicado: (2015)

The Roles of YAP/TAZ and the Hippo Pathway in Healthy and Diseased Skin
por: Rognoni, Emanuel, et al.
Publicado: (2019)

The Roles of Hippo Signaling Transducers Yap and Taz in Chromatin Remodeling
por: Hillmer, Ryan E., et al.
Publicado: (2019)

Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells
por: Van Sciver, Nicholas, et al.
Publicado: (2021)

Epigallocatechin-3-gallate affects the proliferation, apoptosis, migration and invasion of tongue squamous cell carcinoma through the hippo-TAZ signaling pathway
por: Li, Aonan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_arbic8vsb93ss7h9suk2ds8oo6